fludarabine has been researched along with defibrotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreesen, R; Bauer, S; Eissner, G; Gerbitz, A; Haffner, S; Holler, E; Kirchner, S; Multhoff, G; Sondermann, D | 1 |
| Andreesen, R; Blüml, S; Burger, V; Eissner, G; Haffner, S; Holler, E; Iacobelli, M | 1 |
2 other study(ies) available for fludarabine and defibrotide
| Article | Year |
|---|---|
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.
Topics: Apoptosis; Cytotoxicity Tests, Immunologic; Drug Interactions; Endothelium, Vascular; Epithelial Cells; Humans; Immunity; Intercellular Adhesion Molecule-1; Leukocytes; Polydeoxyribonucleotides; Protective Agents; Tumor Cells, Cultured; Vidarabine | 2002 |
Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity.
Topics: Antineoplastic Agents; Cell Line; Cell Movement; Endothelial Cells; Endothelium, Vascular; Oligodeoxyribonucleotides; Polydeoxyribonucleotides; Transplantation Conditioning; Vascular Diseases; Vidarabine | 2005 |